“What I recommend for most of my patients who have significant COPD is to enroll in a pulmonary rehabilitation program .” ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

Before columnist Caroline Gainer figured out how to ask for help with household chores, she found herself stuck in a rut ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

Second Phase 3 Clinical Trial Again Shows Dupilumab Lessens Disease in COPD Patients With Type 2 Inflammation May 20, 2024 — Chronic obstructive pulmonary disease patients with type 2 ...

Distinct patterns of symptom severity among patients with COPD sheds light on the heterogeneous nature of the patients’ ...

It is clinically relevant among patients with COPD and may lead to dyspnea, impaired exercise tolerance ... of the burden of COPD and to develop programs for early detection, prevention, and ...

The following is a summary of "Determining the Impact of COVID-19 Infection on Patients Hospitalized With COPD Exacerbations: ...

The analysis included 96 consecutive patients with a diagnosis of COPD and hospitalized in the internal medicine division between August 2022 and April 2023. HealthDay News — Among patients ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...

Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...